Licensing Strategy

Patent licensing strategy falls into several distinct approaches based on business goals: OFFENSIVE LICENSING (REVENUE GENERATION): the primary goal is generating royalty revenue from the patent portfolio; the company licenses to competitors and non-competitors; may or may not practice the patents itself; patent assertion entities (PAEs)/patent monetization companies are the extreme version; DEFENSIVE LICENSING (FREEDOM TO OPERATE): the primary goal is acquiring rights to practice the technology without infringing third-party patents; in-licensing: pay royalties to license others' blocking patents; cross-licensing: exchange portfolios to zero out royalties (common in tech); patent pools (MPEG LA, Via Licensing): join a pool to license essential patents in a single transaction; STRATEGIC LICENSING (COMPETITIVE POSITIONING): licensing as a competitive strategy beyond pure revenue or FTO; license to friendly parties but not to competitors; license in specific fields to enable ecosystem development; license to standard bodies to promote technology adoption; TECHNOLOGY TRANSFER: universities and research institutions license to startups or established companies for commercialization; exclusive licenses to startups (spinouts); non-exclusive licenses to established companies; STANDARDS LICENSING: companies participating in standards bodies commit to FRAND licensing; this is a mandatory licensing obligation, not a strategic choice; PORTFOLIO-LEVEL vs. PATENT-LEVEL: portfolio licensing: license the entire portfolio for a single payment; avoids need to map specific patents to specific products; single portfolio rate covers all current and future patents; patent-level licensing: identify specific patents covering specific products; negotiate tailored terms for each license; more complex but allows precise value extraction.

Building an effective out-licensing program requires systematic portfolio management and business development: PORTFOLIO AUDIT — THE STARTING POINT: assess what you own; identify patents that cover competitor products or industry practices; rank patents by: strength (claim scope + validity); coverage (breadth of products/industries affected); remaining term; claim construction certainty; IDENTIFYING LICENSING TARGETS: companies whose products practice your patent claims; companies you want as licensees (vs. those you want to maintain as litigation targets); industry groups where portfolio licensing is standard practice; SETTING ROYALTY RATES: use Georgia-Pacific framework for reasonable royalty analysis; benchmark against: comparable licenses (most persuasive); industry royalty rate surveys; patent quality and validity assessments; SET RATES BELOW LITIGATION COST THRESHOLD: a license rate of $50K-$200K may be cheaper for a defendant than defending a lawsuit ($500K+); this encourages settlement; LICENSING APPROACH OPTIONS: (a) DIRECT NEGOTIATION: proactive outreach to potential licensees; relationship-based; preferable for valuable relationships; (b) DEMAND LETTERS: assert the patent and request licensing; can be done at scale; risk of alienating important customers/partners; (c) LITIGATION-BACKED LICENSING: file suit against one target to establish a licensing rate; use the settlement as a pricing signal for others; expensive upfront but establishes market value; (d) INDUSTRY-WIDE PROGRAMS: announce standard rates; many companies accept; PROGRAM STRUCTURE: licensing team (internal IP attorneys or licensing specialists); patent assertion entities (outsourcing to PAEs on contingency); law firms on contingency or reduced rates.

Cross-licensing is a patent-for-patent exchange that enables freedom to operate: WHAT IS CROSS-LICENSING: two companies agree to license their respective patent portfolios to each other; each company can practice the other's patents without paying royalties; the license is typically bilateral and covers all existing and future patents; WHEN CROSS-LICENSING IS APPROPRIATE: both companies have large patent portfolios that cover each other's products; litigation or royalty payments would be mutually costly and disruptive; both companies primarily want freedom to operate; both companies are peers (roughly equal portfolio value); ROYALTY BALANCING: if the portfolios are not equal in value, the party with the weaker portfolio may pay a 'balancing royalty' to equalize the exchange; a company with 50 patents vs. a company with 500 patents may pay a small annual royalty to balance the exchange; CROSS-LICENSING IN TECH INDUSTRIES: smartphone companies (Apple, Samsung, Qualcomm, Nokia, Ericsson) have extensively cross-licensed to avoid mutual litigation; computer hardware companies routinely cross-license; semiconductor manufacturers cross-license process patents; WHAT CROSS-LICENSES DON'T COVER: cross-licenses typically cover patents, not trade secrets; the cross-license doesn't allow copying the other party's products — only using the claimed inventions; design patents are often excluded; PATENT PORTFOLIO BUILDING FOR CROSS-LICENSING: startups building a product that competes with large IP holders must consider: do we have patents to offer in a cross-license exchange?; without a portfolio, the company may face one-sided royalty demands; defensive patent accumulation (buying or building a portfolio purely for cross-licensing leverage) is a common startup strategy; PATENT POOLS AS ORGANIZED CROSS-LICENSING: patent pools (MPEG LA, Via, Avanci) are organized cross-licensing programs for standards-essential patents.

In-licensing is acquiring rights to use third-party patents to remove infringement risk: WHEN IN-LICENSING IS NEEDED: freedom-to-operate analysis identifies a blocking patent; design-around is not technically feasible or too costly; the patent is valid and clearly infringed by a core business activity; THE IN-LICENSING DECISION: compare: cost of license (upfront + ongoing royalties) vs. cost of design-around (engineering + delay) vs. cost of challenging the patent (IPR/PGR $15K-$50K+) vs. risk of continued infringement (treble damages if willful); APPROACHING THE PATENT OWNER: discreet initial inquiry (don't reveal the extent of your concern); understand the patent owner's licensing philosophy (some are easy to license; others use patents for strategic blocking); use intermediaries if the relationship is contentious; NEGOTIATING THE IN-LICENSE: the patent owner's leverage decreases if: the patent is close to expiration; there are alternative design-arounds; the patent faces significant validity challenges; the patent owner values the relationship; the patent owner has other portfolio patents you could counter-license; ACQUIRING PATENTS FOR DEFENSIVE USE: purchase blocking patents before they are asserted against you; 'defensive patent acquisition' firms (RPX Corporation, Allied Security Trust) pool resources to buy and neutralize patent threats; PATENT PLEDGES AND NON-ASSERTION COVENANTS: some companies (Google, Microsoft, IBM) have pledged not to assert certain patents offensively; LOT (License on Transfer) Network: members commit that patents transferred to an NPE (patent assertion entity) automatically become licensed to all other LOT members; JOIN OIN (OPEN INVENTION NETWORK): for Linux-related software patents, OIN members receive cross-licenses from all other OIN members; defensive mechanism for open-source software-adjacent products.

Patent licensing strategy must navigate antitrust, patent misuse, and ethical constraints: PATENT MISUSE: a patent owner who uses the patent beyond its legitimate scope may render the patent unenforceable; traditional patent misuse: tying arrangements (conditioning a patent license on the licensee also buying an unpatented product); post-expiration royalties (Motion Picture Patents Co. v. Universal Film Mfg. Co., S.Ct. 1917; Kimble v. Marvel Entertainment, S.Ct. 2015: post-expiration royalties are per se patent misuse); ANTITRUST AND PATENT LICENSING: licenses that restrain competition may violate Sherman Act § 1 (restraint of trade) or § 2 (monopolization); DOJ/FTC Antitrust Guidelines for Licensing Intellectual Property (2017): integration of complementary assets generally pro-competitive; restrictions anticompetitive only if market power + substantial foreclosure; FRAND ABUSE: SEP holders who demand above-FRAND rates and use injunction threats against willing licensees may face antitrust liability in the EU (Huawei v. ZTE, ECJ 2015); US courts are more permissive about SEP holder conduct; DEMAND LETTER ETHICS: some states have enacted bad-faith patent demand letter statutes; require sufficient information about the patent and infringement theory; overly broad demand letters to non-technical recipients (small businesses, consumers) may violate these statutes; Federal Trade Commission has regulatory authority over deceptive demand letters; SHAM LITIGATION: using litigation primarily as a competitive harassment tool (not to protect patent rights) can create antitrust liability; Walker Process claims: acquiring a patent through fraud + monopolization can create antitrust liability.